{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:25:28Z","timestamp":1780352728593,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12149-021-01598-4","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T13:04:11Z","timestamp":1615208651000},"page":"557-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer\/T-cell lymphoma"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-9162","authenticated-orcid":false,"given":"Hian Liang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Ing","family":"Ngam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khee Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chee Eng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Thye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Yongsheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"issue":"2","key":"1598_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1470-2045(19)30799-5","volume":"21","author":"GW Lin","year":"2020","unstructured":"Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, et al. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations. Lancet Oncol. 2020;21(2):306\u201316.","journal-title":"Lancet Oncol"},{"issue":"17","key":"1598_CR2","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-Cell lymphoma project. Blood. 2009;113(17):3931\u20137.","journal-title":"Blood"},{"issue":"4","key":"1598_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12185-018-2406-6","volume":"107","author":"JY Chan","year":"2018","unstructured":"Chan JY, Lim ST. Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas. Int J Hematol. 2018;107(4):413\u20139.","journal-title":"Int J Hematol"},{"issue":"3","key":"1598_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(3):389\u2013400.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1598_CR5","doi-asserted-by":"publisher","first-page":"14962","DOI":"10.1038\/s41598-019-51488-z","volume":"9","author":"KM Tan","year":"2019","unstructured":"Tan KM, Chia B, Lim JQ, Khoo LP, Cheng CL, Tan L, et al. A clinicohaematological prognostic model for nasal-type natural killer\/T-cell lymphoma: a multicenter study. Sci Rep. 2019;9(1):14962.","journal-title":"Sci Rep"},{"issue":"1","key":"1598_CR6","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41598-020-61378-4","volume":"10","author":"RMH Lim","year":"2020","unstructured":"Lim RMH, Chan NPX, Khoo LP, Cheng CL, Tan L, Poon EYL, et al. A clinico-genotypic prognostic index for de novo composite diffuse large B-cell lymphoma arising from follicular lymphoma in Asian patients treated in the rituximab era. Sci Rep. 2020;10(1):4373.","journal-title":"Sci Rep"},{"issue":"27","key":"1598_CR7","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, M\u00fceller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048\u201358.","journal-title":"J Clin Oncol"},{"key":"1598_CR8","volume-title":"Interim PET-results for prognosis in adults with hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies","author":"A Aldin","year":"2019","unstructured":"Aldin A, Umlauff L, Estcourt LJ, Collins G, Moons KGM, Engert A, et al. Interim PET-results for prognosis in adults with hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies, vol. 2019. Wiley: Cochrane Database of Systematic Reviews; 2019."},{"issue":"3","key":"1598_CR9","doi-asserted-by":"publisher","first-page":"e0194435","DOI":"10.1371\/journal.pone.0194435","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang H, Shen G, Jiang C, Li L, Cui F, Tian R. Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET\/CT parameters in extranodal natural killer\/T-cell lymphoma: a meta-analysis. PLoS ONE. 2018;13(3):e0194435.","journal-title":"PLoS ONE"},{"issue":"1","key":"1598_CR10","doi-asserted-by":"publisher","first-page":"11959","DOI":"10.1038\/s41598-018-30442-5","volume":"8","author":"JY Chan","year":"2018","unstructured":"Chan JY, Zhang Z, Chew W, Tan GF, Lim CL, Zhou L, et al. Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma. Sci Rep. 2018;8(1):11959.","journal-title":"Sci Rep"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"issue":"8","key":"1598_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00277-008-0494-8","volume":"87","author":"PL Khong","year":"2008","unstructured":"Khong PL, Pang CBY, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87(8):613\u201321.","journal-title":"Ann Hematol"},{"issue":"11","key":"1598_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/MNM.0000000000000731","volume":"38","author":"C Jiang","year":"2017","unstructured":"Jiang C, Liu J, Li L, Kosik RO, Su M, Zou L, et al. Predictive approaches for post-therapy PET\/CT in patients with extranodal natural killer\/T-cell lymphoma: a retrospective study. Nucl Med Commun. 2017;38(11):937\u201347.","journal-title":"Nucl Med Commun"},{"issue":"9","key":"1598_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","volume":"40","author":"CY Kim","year":"2013","unstructured":"Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW, et al. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma. Eur J Nucl Med Mol Imaging. 2013;40(9):1321\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1598_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","volume":"10","author":"E Tse","year":"2017","unstructured":"Tse E, Kwong YL. The diagnosis and management of NK\/T-cell lymphomas. J Hematol Oncol. 2017;10(1):85.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1598_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12032-012-0339-0","volume":"30","author":"B Bai","year":"2013","unstructured":"Bai B, Huang HQ, Cai QC, Fan W, Wang XX, Zhang X, et al. Predictive value of pretreatment positron emission tomography\/computed tomography in patients with newly diagnosed extranodal natural killer\/T-cell lymphoma. Med Oncol. 2013;30(1):339.","journal-title":"Med Oncol"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1933719115618282","volume":"24","author":"Y Chang","year":"2017","unstructured":"Chang Y, Fu X, Sun Z, Xie X, Wang R, Li Z, et al. Utility of baseline, interim and end-of-treatment 18F-FDG PET\/CT in extranodal natural killer\/T-cell lymphoma patients treated with l-asparaginase\/pegaspargase. Sci Rep. 2017;24:7.","journal-title":"Sci Rep"},{"issue":"5","key":"1598_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54(5):683\u201390.","journal-title":"J Nucl Med"},{"issue":"11","key":"1598_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","volume":"93","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, et al. Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study. Ann Hematol. 2014;93(11):1895\u2013901.","journal-title":"Ann Hematol"},{"issue":"6","key":"1598_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.113.131946","volume":"55","author":"PL Khong","year":"2014","unstructured":"Khong PL, Huang B, Lee EYP, Chan WKS, Kwong YL. Midtreatment 18F-FDG PET\/CT scan for early response assessment of SMILE therapy in natural killer\/T-cell lymphoma: a prospective study from a single center. J Nucl Med. 2014;55(6):911\u20136.","journal-title":"J Nucl Med"},{"issue":"4","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2967\/jnumed.112.110262","volume":"54","author":"Y-J Li","year":"2013","unstructured":"Li Y-J, Li Z-M, Xia X-Y, Huang H-Q, Xia Z-J, Lin T-Y, et al. Prognostic value of interim and posttherapy 18F-FDG PET\/CT in patients with mature T-cell and natural killer cell lymphomas. J Nucl Med. 2013;54(4):507\u201315.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01598-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:55:04Z","timestamp":1619531704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01598-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01598-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interests or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Written consent for use of biospecimens and clinical data were obtained in accordance with the Declaration of Helsinki. Tissue collection and consent protocols were performed as part of the Singapore Lymphoma Study and were under approval from the SingHealth Centralized Institution Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data generated or analysed during this study are included in this published article. The dataset analysed is available from the corresponding author on appropriate request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}}]}}